Life Technologies Seeks to Raise $1.5B from Senior Notes Sale | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life Technologies intends to raise $1.5 billion from the sale of senior notes due in three years, five years, and 10 years.

The first tranche for $250 million in 3.375 percent notes matures March 1, 2013; the second tranche of $500 million in 4.4 percent notes matures March 1, 2015; and the third tranche of $750 million in 6 percent notes matures March 1, 2020.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."